GlassScriptPhysician profile
Richard A Podolin
NPI 1295876860
$19,584.57
in general payments reported to CMS, 2019-2025
52 companies · $2,811 in 2025
The $2,811 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,081 · 2020: $1,982 · 2021: $2,809 · 2022: $3,258 · 2023: $3,177 · 2024: $3,466 · 2025: $2,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,598 · Travel and Lodging: $846 · Education: $10.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,597.85 |
| Travel and Lodging | $845.96 |
| Education | $10.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,654.56 | 2019-2025 | |
| Amgen INC. | $1,585.48 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,395.83 | 2021-2025 | Aveir, Cardiomems, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $1,381.32 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,330.74 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $1,293.72 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $919.47 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $901.69 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $880.16 | 2019-2024 | Xarelto |
| Pfizer INC. | $776.09 | 2020-2025 | |
| Novo Nordisk INC | $741.50 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $633.18 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $573.24 | 2021-2025 | Verquvo, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $544.02 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $529.60 | 2019-2024 | Opsumit, Uptravi |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $440.86 | 2020-2022 | |
| Boston Scientific Corporation | $422.52 | 2019-2025 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $301.80 | 2023-2025 | Amvuttra |
| Edwards Lifesciences Corporation | $285.02 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Irhythm Technologies, INC. | $274.06 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $253.59 | 2021-2025 | Endurant Iis |
| Amarin Pharma, INC. | $237.11 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $218.97 | 2022-2023 | Optimizer |
| Chiesi USA, INC. | $216.02 | 2021-2024 | Kengreal, Cleviprex |
| Medtronic Vascular, INC. | $215.25 | 2019-2020 | |
| Heartflow, INC. | $189.13 | 2019-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $185.59 | 2021-2023 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $168.62 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $153.90 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $101.71 | 2023-2025 | |
| Astellas Pharma US INC | $72.70 | 2020-2021 | |
| Cathworks, INC. | $68.05 | 2020-2022 | |
| Osprey Medical INC | $62.00 | 2019 | |
| Bridgebio Pharma, INC. | $47.18 | 2025 | Attruby |
| Philips North America LLC | $44.55 | 2024 | (5044) Mcot |
| Baxter Healthcare | $43.14 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lundbeck LLC | $41.43 | 2020-2021 | |
| Shockwave Medical, INC | $40.51 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Agepha Pharma Fz LLC | $38.76 | 2025 | Lodoco |
| Angiodynamics, INC. | $38.29 | 2021 | |
| Atricure, INC. | $36.96 | 2024 | |
| Cardiovascular Systems INC. | $35.52 | 2022-2023 | Diamondback Coronary |
| Biotronik INC. | $27.46 | 2023 | Biomonitor |
| Terumo Medical Corporation | $23.31 | 2019 | |
| Arbor Pharmaceuticals, INC. | $23.18 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $23.15 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $21.84 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.98 | 2021 | |
| Azurity Pharmaceuticals, INC. | $19.35 | 2025 | Alvesco |
| Medicomp INC | $18.23 | 2021 | |
| Inari Medical, INC. | $17.07 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Podolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.